Antibodies have drawn a spotlight over the past year and a half as scientists and lay people alike have asked how long the infection-fighting proteins persist in the face of a formidable enemy—a pandemic virus that has ...
Two experimental malaria vaccines are not only safe for humans, one of those immunizations prompted a slowing of the malaria parasite's replication in the bloodstream of clinical trial participants, scientists have found ...
Scientists are unraveling the complex mystery underlying how the immune system mounts a potent defense against one of the world's most relentless killers—the deadly parasites that cause the worst form of malaria.
(Medical Xpress) -- Malaria is a disease caused by parasites passed to humans via the bites of infected mosquitoes. Globally, the disease causes over a million deaths every year, and is especially rife in parts of Africa ...
The most common type of malaria in Brazil is caused by the parasite Plasmodium vivax. Although vivax malaria is milder than the variant caused by P. falciparum, the ability of P. vivax to produce dormant forms in the host's ...
Jun 24, 2024
0
15
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical ...
Apr 26, 2024
0
23
Genetic diversity of the malaria parasite in pregnant women and children declined in an area targeted for malaria elimination in Mozambique, according to a study led by the Barcelona Institute for Global Health (ISGlobal). ...
Mar 19, 2024
0
20
Structural insights into a potent antimalarial drug candidate's interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study by researchers ...
Jan 18, 2024
0
7
An international research team has revealed how Plasmodium vivax, one of the main causes of malaria, is capable of infecting people in Africa. This is an important discovery, given that until now these populations were considered ...
Dec 8, 2023
0
43
A clinical trial by Menzies School of Health Research (Menzies) published in The Lancet has revealed promising results to reduce malaria relapses, through the broader use of primaquine.
Nov 16, 2023
0
55
